Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER1 | P34995 | 2/20 | 0.40 |
| ▸ | RORA | P35398 | 1/20 | 0.40 |
| ▸ | NR2E1 | Q9Y466 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.38 |
| ▸ | GPR142 | Q7Z601 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.37 |
| ▸ | PSEN1 | P49768 | 6/20 | 0.36 |
| ▸ | PSEN2 | P49810 | 6/20 | 0.36 |
| ▸ | APH1B | Q8WW43 | 6/20 | 0.36 |
| ▸ | NCSTN | Q92542 | 6/20 | 0.36 |
| ▸ | APH1A | Q96BI3 | 6/20 | 0.36 |
| ▸ | PSENEN | Q9NZ42 | 6/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2686188 | 1.00 | PTGER1 (0.40) | PTGER1RORANR2E1CYP3A4CYP2C9 | |
| SCHEMBL2683765 | 0.94 | RORA (0.40) | PTGER1RORANR2E1CYP3A4CYP2C9 | |
| SCHEMBL2683768 | 0.94 | RORA (0.40) | PTGER1RORANR2E1CYP3A4CYP2C9 | |
| SCHEMBL13258419 | 0.87 | AAK1 (0.41) | PTGER1RORANR2E1CYP3A4CYP2C9 | |
| SCHEMBL2685594 | 0.84 | HDAC8 (0.45) | PTGER1RORANR2E1CYP3A4CYP2C9 | |
| SCHEMBL2685599 | 0.84 | HDAC8 (0.45) | PTGER1RORANR2E1CYP3A4CYP2C9 | |
| SCHEMBL13258426 | 0.81 | AAK1 (0.41) | RORANR2E1AAK1GPR142MAPK1 | |
| SCHEMBL2684203 | 0.74 | GPR142 (0.55) | PTGER1GPR142 | |
| SCHEMBL2685750 | 0.72 | IDO1 (0.47) | CYP3A4CYP2C9KDM4EMEN1KMT2A | |
| SCHEMBL2685745 | 0.72 | IDO1 (0.47) | CYP3A4CYP2C9KDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785468-B2 | Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions | AMGEN INC. (US) | 2014-07-22 | — | — | US | disclosed |
| US-20120115811-A1 | PHENYLANALINE AMIDE DERIVATIVES USEFUL FOR TREATING INSULIN-RELATED DISEASES AND CONDITIONS | AMGEN INC. (US) | 2012-05-10 | — | — | US | disclosed |
| WO-2010093849-A2 | PHENYLALANINE AMIDE DERIVATIVES USEFUL FOR TREATING INSULIN-RELATED DISEASES AND CONDITIONS | AMGEN INC. (US) | 2010-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120115811-A1 | PHENYLANALINE AMIDE DERIVATIVES USEFUL FOR TREATING INSULIN-RELATED DISEASES AND CONDITIONS | IAPP, INSR, AMY2A | PTGER1 1207/4885RORA 3188/4885NR2E1 390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.